CRISPR-Cas systems have revolutionized genetic engineering, offering a precise and efficient platform for genome editing.  This review summarizes the current applications and limitations of CRISPR technology in various fields.  Its ease of use, compared to previous methods like ZFNs and TALENs, has facilitated widespread adoption across diverse research areas, including gene therapy, agricultural biotechnology, and disease modeling.  Significant progress has been made in improving targeting specificity and reducing off-target effects, although challenges remain in delivering the CRISPR-Cas system to target cells and tissues effectively.  Furthermore, ethical concerns regarding germline editing and unintended consequences of widespread genome modification require careful consideration.  While current applications primarily focus on gene knockout and knock-in strategies, advancements in base editing and prime editing are expanding the scope of possible genetic alterations.  Ongoing research aims to refine CRISPR technology's precision and broaden its therapeutic potential, paving the way for novel treatments and agricultural innovations.  However, rigorous safety assessments and ethical frameworks are crucial to ensure responsible and beneficial implementation of this powerful technology.